PRTK - Paratek Pharmaceuticals - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

PRTK is currently covered by 3 analysts with an average price target of $15.59. This is a potential upside of $13.36 (599.1%) from yesterday's end of day stock price of $2.23.

Paratek Pharmaceuticals's activity chart (see below) currently has 32 price targets and 33 ratings on display. The stock rating distribution of PRTK is 33.33% BUY and 66.67% HOLD.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 15% with an average time for these price targets to be met of 42.38 days.

Highest price target for PRTK is $2, Lowest price target is $1, average price target is $15.59.

Most recent stock forecast was given by ED ARCE from HC WAINWRIGHT on 07-Aug-2023. First documented stock forecast 29-Feb-2016.

Currently out of the existing stock ratings of PRTK, 2 are a BUY (33.33%), 4 are a HOLD (66.67%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Hold

$2.15

$-0.08 (-3.59%)

$2.15

1 years 3 months 14 days ago
(07-Aug-2023)

0/9 (0%)

$-0.05 (-2.27%)

Hold

$2.15

$-0.08 (-3.59%)

$15

1 years 5 months 14 days ago
(07-Jun-2023)

0/2 (0%)

$-0.11 (-4.87%)

Buy

1 years 8 months 4 days ago
(17-Mar-2023)

0/1 (0%)

$33.7 (253.38%)

Buy

$10

2 years 9 months 11 days ago
(10-Feb-2022)

2/2 (100%)

$2.03 (36.21%)

150

Buy

$11

4 years 3 months 10 days ago
(11-Aug-2020)

0/5 (0%)

$7.1 (182.05%)

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is PRTK (Paratek Pharmaceuticals) average time for price targets to be met?

On average it took 42.38 days on average for the stock forecasts to be realized with a an average price target met ratio 15

Which analyst has the current highest performing score on PRTK (Paratek Pharmaceuticals) with a proven track record?

STEVE BROZAK

Which analyst has the current lower performing score on PRTK (Paratek Pharmaceuticals) with a proven track record?

SUJI JEONG

Which analyst has the most public recommendations on PRTK (Paratek Pharmaceuticals)?

Steve Brozak works at WBB and has 94 price targets and 342 ratings on PRTK

Which analyst is the currently most bullish on PRTK (Paratek Pharmaceuticals)?

Louise Chen with highest potential upside - $47.77

Which analyst is the currently most reserved on PRTK (Paratek Pharmaceuticals)?

Ed Arce with lowest potential downside - -$0.08

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?